These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32951459)

  • 1. Topical insulin for refractory persistent corneal epithelial defects.
    Diaz-Valle D; Burgos-Blasco B; Gegundez-Fernandez JA; Garcia-Caride S; Puebla-Garcia V; Peña-Urbina P; Benitez-Del-Castillo JM
    Eur J Ophthalmol; 2021 Sep; 31(5):2280-2286. PubMed ID: 32951459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical insulin for refractory persistent corneal epithelial defects.
    Abdi P; Ghaffari R; Azad N; Alshaheeb A; Latifi G; Soltani Shahgoli S; Fakhredin H
    Sci Rep; 2024 May; 14(1):12459. PubMed ID: 38816428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing of Chemical Injury-Related Persistent Corneal Epithelial Defects With Topical Insulin.
    Balal S; Din N; Ashton C; Ahmad S
    Cornea; 2023 Aug; 42(8):1000-1004. PubMed ID: 36729695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of topical insulin for recurrent epithelial corneal erosions.
    Esmail A; Ibrahim M; Nage S
    Ir J Med Sci; 2023 Dec; 192(6):3117-3123. PubMed ID: 37140764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea.
    Diaz-Valle D; Burgos-Blasco B; Rego-Lorca D; Puebla-Garcia V; Perez-Garcia P; Benitez-Del-Castillo JM; Herrero-Vanrell R; Vicario-de-la-Torre M; Gegundez-Fernandez JA
    Acta Ophthalmol; 2022 Jun; 100(4):e912-e919. PubMed ID: 34407296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of epidermal growth factor ointment on persistent epithelial defects of the cornea.
    Moon HS; Li L; Yoon HJ; Ji YS; Yoon KC
    BMC Ophthalmol; 2020 Apr; 20(1):147. PubMed ID: 32295556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.
    Jeng BH; Hamrah P; Kirshner ZZ; Mendez BC; Wessel HC; Brown LR; Steed DL
    Transl Vis Sci Technol; 2022 Jan; 11(1):8. PubMed ID: 34994777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finger-Prick Autologous Blood in the Treatment of Persistent Corneal Epithelial Defects.
    Balal S; Nitiahpapand R; Hassan A; Than J; Patel A; Kumar B; Sharma A
    Cornea; 2020 May; 39(5):594-597. PubMed ID: 31868852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects.
    Schrader S; Wedel T; Moll R; Geerling G
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1345-9. PubMed ID: 16544115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops.
    Napoli PE; Braghiroli M; Iovino C; Demarinis G; Fossarello M
    Drug Des Devel Ther; 2019; 13():2001-2008. PubMed ID: 31354245
    [No Abstract]   [Full Text] [Related]  

  • 11. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe ocular surface disorders with albumin eye drops.
    Schargus M; Kohlhaas M; Unterlauft JD
    J Ocul Pharmacol Ther; 2015 Jun; 31(5):291-5. PubMed ID: 25853388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic outcomes of combined topical autologous serum eye drops with silicone-hydrogel soft contact lenses in the treatment of corneal persistent epithelial defects: A preliminary study.
    Lee YK; Lin YC; Tsai SH; Chen WL; Chen YM
    Cont Lens Anterior Eye; 2016 Dec; 39(6):425-430. PubMed ID: 27349951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open clinical study of eye drops containing the fibronectin-derived peptide PHSRN for treatment of persistent corneal epithelial defects.
    Yamada N; Morishige N; Yanai R; Morita Y; Kimura K; Chikama T; Nomizu M; Sonoda KH; Nishida T
    Cornea; 2012 Dec; 31(12):1408-13. PubMed ID: 23135532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Controlled Trial of Topical Insulin for Healing Corneal Epithelial Defects Induced During Vitreoretinal Surgery in Diabetics.
    Fai S; Ahem A; Mustapha M; Mohd Noh UK; Bastion MC
    Asia Pac J Ophthalmol (Phila); 2017; 6(5):418-424. PubMed ID: 28828764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies.
    Poon AC; Geerling G; Dart JK; Fraenkel GE; Daniels JT
    Br J Ophthalmol; 2001 Oct; 85(10):1188-97. PubMed ID: 11567963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Insulin-Utility and Results in Refractory Neurotrophic Keratopathy in Stages 2 and 3.
    Soares RJDSM; Arêde C; Sousa Neves F; da Silva Fernandes J; Cunha Ferreira C; Sequeira J
    Cornea; 2022 Aug; 41(8):990-994. PubMed ID: 34483270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular surface restoration using non-surgical transplantation of tissue-cultured human amniotic epithelial cells.
    Parmar DN; Alizadeh H; Awwad ST; Li H; Neelam S; Bowman RW; Cavanagh HD; McCulley JP
    Am J Ophthalmol; 2006 Feb; 141(2):299-307. PubMed ID: 16458684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects.
    Jeng BH; Dupps WJ
    Cornea; 2009 Dec; 28(10):1104-8. PubMed ID: 19730088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes of In-office Sutureless Amniotic Membrane Transplantation in Persistent Epithelial Defect.
    Choi CM; Jeon HS
    Korean J Ophthalmol; 2022 Apr; 36(2):87-96. PubMed ID: 34823345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.